Incyte
INCY
#975
Rank
C$33.50 B
Marketcap
C$164.37
Share price
-1.07%
Change (1 day)
14.63%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): C$2.85

According to Incyte's latest financial reports the company's current EPS (TTM) is C$3.01. In 2025 the company made an earnings per share (EPS) of C$9.46 an increase over its 2024 EPS that were of C$0.44.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$2.85-69.91%
2025C$9.462029.03%
2024C$0.44-88.39%
2023C$3.8373.38%
2022C$2.21-64.1%
2021C$6.15-408.63%
2020C-$1.99-166.83%
2019C$2.98300%
2018C$0.75-133.33%
2017C-$2.24-378.57%
2016C$0.802700%
2015C$0.02868-106.67%
2014C-$0.43-44.44%
2013C-$0.7750%
2012C-$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.53 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-66.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.30 1,370.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.92 727.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.71 23.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.11-103.81%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C-$0.83-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C-$1.20-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C-$0.32-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA